glp-1-based therapy GLP-1 therapy's potential in treating heart, brain, and liver diseases beyond diabetes Insights into incretin-based therapies for

Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonist finerenone in the management of diabetic kidney disease: A meta-analysis

Following a balanced diet is important when taking GLP-1 medications because it can help improve the effectiveness of the medication in managing blood sugar levels and weight

For a comprehensive review of the anti-obesity effects of GLP-1RAs, which is beyond the purpose of this article, see ref

Earlier GLP-1R agonists could cross into the brain and do have effects on the mouse model of Alzheimers disease, but the newer drugs have been designed to stay in the blood for a very long time and do not really cross into the brain, said Hlscher

If powder remains, swirl the vial slowly or roll it between your palms